FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3213378985> ?p ?o ?g. }

• W3213378985 endingPage "A623" @default.
• W3213378985 startingPage "A623" @default.
• W3213378985 abstract "Background Breast cancer is viewed as immunologically cold, imposing an immune-suppressive tumor microenvironment and responding poorly to lone immune checkpoint blockade. As an adjunct to ICB, radiation therapy holds promise in terms of in situ tumor vaccination effect, although it is known to promote immune suppression, increasing regulatory T cells, myeloid-derived suppressor cell, and M2 tumor-associated macrophages. It was our contention that combined use of RT and a PI3Kγδ inhibitor to combat immune suppression might enhance the efficacy of ICB. Methods Murine breast cancer cells (4T1) were grown in both immune-competent and -deficient BALB/c mice, and tumors were irradiated by 3 fractions of 24 Gy. A PD-1 blockade and a PI3Kγδ inhibitor were then administered every other day for 2 weeks. Tumors from humanized patient-derived breast cancer xenograft model was sequenced to identify immune-related pathways and to profile infiltrated immune cells. Transcriptomic and clinical data were acquired from The Cancer Genome Atlas pan-cancer cohort, and the deconvolution algorithm was used to profile immune cell repertoire. Results In the immune-competent syngenic 4T1 murine tumor model, PD-1 blockade alone led to tumor hyperprogression, whereas a three-pronged strategy of PI3Kγδ inhibitor, RT, and PD-1 blockade significantly delayed primary tumor growth, boosted abscopal effect, and improved animal survival by comparison. The immune-deficient syngenic 4T1 murine tumor model failed to show this synergism in delaying tumor growth and the abscopal effect. According to FACS analysis, RT significantly increased not only CD8+cytotoxic T-cell fractions but also immune-suppressive Treg cells, MDSCs, and M2 TAMs. However, PI3Kγδ inhibitor significantly lowered proportions of Treg, MDSCs, and M2 TAMs, achieving dramatic gains in splenic, nodal, and tumor CD8+ T-cell populations after triple combination therapy. There were significantly decreased tumor expressions of p-AKT, PD-L1, and HIF1α by PI3Kγδ inhibition. Triple combination therapy significantly delayed primary tumor growth in humanized PDX model as well and analyses of RNA sequencing data of humanized PDX samples showed decreased immune suppressive pathways with decreased and M2 macrophage and increased CD8+ T-cell by triple combination therapy. In the TCGA pan-cancer cohort, high Treg/CD8+T-cell and M2/M1 TAM ratios and poor overall patient survival was associated with high PIK3CG (PI3Kγ) or PIK3CD (PI3Kδ) gene expression. Conclusions These findings collectively indicate that PI3Kγ and PI3Kδ are clinically relevant targets in an immunosuppressive TME. Combining PI3Kγδ inhibitor, RT, and PD-1 blockade may thus be a viable approach, helping to overcome the therapeutic resistance of immunologically cold tumors such as breast cancer." @default.
• W3213378985 created "2021-11-22" @default.
• W3213378985 creator A5002326519 @default.
• W3213378985 creator A5054417980 @default.
• W3213378985 creator A5070384936 @default.
• W3213378985 creator A5078350339 @default.
• W3213378985 creator A5079181340 @default.
• W3213378985 date "2021-11-01" @default.
• W3213378985 modified "2023-09-27" @default.
• W3213378985 title "593 PI3Kγδ inhibitor combined with radiation enhances the antitumor immune effect of PD-1 blockade in syngenic murine breast cancer model and humanized patient-derived xenograft model" @default.
• W3213378985 doi "https://doi.org/10.1136/jitc-2021-sitc2021.593" @default.
• W3213378985 hasPublicationYear "2021" @default.
• W3213378985 type Work @default.
• W3213378985 sameAs 3213378985 @default.
• W3213378985 citedByCount "0" @default.
• W3213378985 crossrefType "journal-article" @default.
• W3213378985 hasAuthorship W3213378985A5002326519 @default.
• W3213378985 hasAuthorship W3213378985A5054417980 @default.
• W3213378985 hasAuthorship W3213378985A5070384936 @default.
• W3213378985 hasAuthorship W3213378985A5078350339 @default.
• W3213378985 hasAuthorship W3213378985A5079181340 @default.
• W3213378985 hasBestOaLocation W32133789851 @default.
• W3213378985 hasConcept C121608353 @default.
• W3213378985 hasConcept C126322002 @default.
• W3213378985 hasConcept C154317977 @default.
• W3213378985 hasConcept C167672396 @default.
• W3213378985 hasConcept C170493617 @default.
• W3213378985 hasConcept C202751555 @default.
• W3213378985 hasConcept C203014093 @default.
• W3213378985 hasConcept C2776107976 @default.
• W3213378985 hasConcept C2777701055 @default.
• W3213378985 hasConcept C2778468042 @default.
• W3213378985 hasConcept C2779193416 @default.
• W3213378985 hasConcept C2780674031 @default.
• W3213378985 hasConcept C2780851360 @default.
• W3213378985 hasConcept C502942594 @default.
• W3213378985 hasConcept C530470458 @default.
• W3213378985 hasConcept C55493867 @default.
• W3213378985 hasConcept C71924100 @default.
• W3213378985 hasConcept C86803240 @default.
• W3213378985 hasConcept C8891405 @default.
• W3213378985 hasConceptScore W3213378985C121608353 @default.
• W3213378985 hasConceptScore W3213378985C126322002 @default.
• W3213378985 hasConceptScore W3213378985C154317977 @default.
• W3213378985 hasConceptScore W3213378985C167672396 @default.
• W3213378985 hasConceptScore W3213378985C170493617 @default.
• W3213378985 hasConceptScore W3213378985C202751555 @default.
• W3213378985 hasConceptScore W3213378985C203014093 @default.
• W3213378985 hasConceptScore W3213378985C2776107976 @default.
• W3213378985 hasConceptScore W3213378985C2777701055 @default.
• W3213378985 hasConceptScore W3213378985C2778468042 @default.
• W3213378985 hasConceptScore W3213378985C2779193416 @default.
• W3213378985 hasConceptScore W3213378985C2780674031 @default.
• W3213378985 hasConceptScore W3213378985C2780851360 @default.
• W3213378985 hasConceptScore W3213378985C502942594 @default.
• W3213378985 hasConceptScore W3213378985C530470458 @default.
• W3213378985 hasConceptScore W3213378985C55493867 @default.
• W3213378985 hasConceptScore W3213378985C71924100 @default.
• W3213378985 hasConceptScore W3213378985C86803240 @default.
• W3213378985 hasConceptScore W3213378985C8891405 @default.
• W3213378985 hasIssue "Suppl 3" @default.
• W3213378985 hasLocation W32133789851 @default.
• W3213378985 hasLocation W32133789852 @default.
• W3213378985 hasOpenAccess W3213378985 @default.
• W3213378985 hasPrimaryLocation W32133789851 @default.
• W3213378985 hasRelatedWork W2049209548 @default.
• W3213378985 hasRelatedWork W2803061034 @default.
• W3213378985 hasRelatedWork W3134152892 @default.
• W3213378985 hasRelatedWork W3153709335 @default.
• W3213378985 hasRelatedWork W3177607563 @default.
• W3213378985 hasRelatedWork W3217412908 @default.
• W3213378985 hasRelatedWork W4281389645 @default.
• W3213378985 hasRelatedWork W4285731353 @default.
• W3213378985 hasRelatedWork W4309469576 @default.
• W3213378985 hasRelatedWork W4378715746 @default.
• W3213378985 hasVolume "9" @default.
• W3213378985 isParatext "false" @default.
• W3213378985 isRetracted "false" @default.
• W3213378985 magId "3213378985" @default.
• W3213378985 workType "article" @default.